GRIFOLS | GRF - Operating Expenses


GRIFOLS reported EUR1.55B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Alcon AG USD 2.78B 370M Jun/2026
Almirall EUR 531.16M 13.76M Jun/2026
Amadeus IT EUR 1.17B 17.5M Jun/2026
Amarin USD 51.48M 113K Dec/2025
argenx SE USD 1.02B 118M Jun/2026
AstraZeneca USD 12.22B 4.04B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
Cie Automotive EUR 1.69B 20.74M Dec/2025
Demant DKK 10.79B 1.16B Jun/2026
Ence Energia y Celulosa EUR 188.7M 35.73M Mar/2026
Essilor EUR 12.52B 568M Jun/2026
Ferrovial EUR 4.21B 412M Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.32B 20.7M Jun/2026
Genmab DKK 748M 77M Jun/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
GRIFOLS EUR 1.55B 94M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Inditex EUR 6.99B 2.64B Mar/2026
Lakefront Biotherapeutics EUR 55.62M 14.56M Jun/2026
Merck EUR 4.34B 249M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Philips EUR 3.75B 147M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Smith & Nephew USD 2.59B 71M Jun/2026
UCB EUR 2.96B 196M Dec/2025
Viscofan EUR 275.44M 12.84M Jun/2026